| Symbol | ACET |
|---|---|
| Name | ADICET BIO, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 200 CLARENDON STREET,FLOOR 6, BOSTON, Massachusetts, 02116, United States |
| Telephone | +1 650 503-9095 |
| Fax | — |
| — | |
| Website | https://www.adicetbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - Adicet Bio, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001346824-26-000105 <b>Size:</b> 15 KB
Read moreNew Form 3 - Adicet Bio, Inc. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0001231919-26-000335 <b>Size:</b> 12 KB
Read moreNew Form SCHEDULE 13D/A - Adicet Bio, Inc. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0000947871-26-000427 <b>Size:</b> 49 KB
Read more📋 OrbiMed Genesis Master Fund, L.P. (Shareholder) plans to sell 78K shares of Adicet Bio, Inc. (at $6.55 each, total $514K) Filed: Apr 09, 2026 | ID: 000420
Read more📋 OrbiMed Israel Partners II, L.P. (Shareholder) plans to sell 40K shares of Adicet Bio, Inc. (at $6.55 each, total $265K) Filed: Apr 08, 2026 | ID: 000417
Read more📋 OrbiMed Israel Partners Limited Partnership (Shareholder) plans to sell 64K shares of Adicet Bio, Inc. (at $6.43 each, total $413K) Filed: Apr 07, 2026 | ID: 000413
Read moreHarvey Brian Nicholas 🟢 acquired 43.4K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $6.81 Transaction Date: Mar 25, 2026 | Filing ID: 000002
Read moreSchor Chen 🟢 acquired 468.6K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $6.81 ($3.2M) Transaction Date: Mar 25, 2026 | Filing ID: 000003
Read moreHealey Don 🟢 acquired 43.4K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $6.81 Transaction Date: Mar 25, 2026 | Filing ID: 000002
Read moreAftab Blake 🟢 acquired 72.6K shares (1 derivative) of Adicet Bio, Inc. (ACET) at $6.81 Transaction Date: Mar 25, 2026 | Filing ID: 000002
Read more